Home
Contact
✕
Targeted therapy
Home
Targeted therapy
Filter by
Categories
Tags
Authors
Show all
All
Editorials
New Trials
Ongoing Trials
Trial Results
All
Acute lymphoblastic leukemia
Adolescents and young adults
Advocacy
Anal cancer
Antioxidants
Bladder cancer
Blood cancers
Breast cancer
Cancer care delivery
Caregiving
Chemotherapy
Chronic lymphocytic leukemia
ComboMATCH
Communication
COVID-19
De-escalation
Esophagus cancer
GI cancer
Green tea
Head and neck cancer
Health equity
HER2+ breast cancer
Hormone therapy
Immune system therapy
Immunotherapy
In memory
Kidney cancer
Language
Late Effects
Leukemia
Liver cancer
Lung cancer
Lymphoma
Mammography
Mantle cell lymphoma
Melanoma
Mesothelioma
Minimal residual disease
MRI
Multiple myeloma
Myeloma
National Clinical Trials Network
NCI-MATCH
Neuropathy
Nose and sinus cancer
Older adults
Pancreatic cancer
Pancreatic cysts
Patient care
Patient education
Patient-reported outcomes
Personalized medicine
Personalized screening
Personalized treatment
Precision medicine
Prevention
Prostate cancer
Renal cell carcinoma
Screening
Side effects
Smoldering multiple myeloma
Squamous cell carcinoma
Surveillance
Survivorship
Symptom management
Targeted therapy
Throat cancer
Triple-negative breast cancer
Tumor test
All
Diane Dragaud
ECOG-ACRIN Staff
Katie Heller
December 15, 2021
December 15, 2021
Categories
Trial Results
Trial Results: The DREAMseq trial provides strong evidence for a new treatment sequence for patients with BRAF-mutated advanced melanoma skin cancer
Dr. Michael Atkins, a medical oncologist who specializes in melanoma, talks about the results of the DREAMseq trial and how the information will hopefully extend life for more patients with advanced melanoma
June 24, 2021
June 24, 2021
Categories
Editorials
Ongoing Trial: For patients with advanced or rare cancers, NCI-MATCH may offer a treatment option
Each arm of NCI-MATCH—and every patient who participates—provide valuable information on potential cancer treatments.
February 12, 2020
February 12, 2020
Categories
Trial Results
Trial Results: New TAILORx data shows chemotherapy benefit for women at high risk of breast cancer recurrence
The TAILORx trial answers questions about when to use chemotherapy to treat the most common type of breast cancer.
February 9, 2020
February 9, 2020
Categories
New Trials
Now Enrolling: Trial EA4181 is comparing three different chemotherapy treatments for newly diagnosed mantle cell lymphoma
Right now, researchers do not know the ideal treatment for people with newly diagnosed mantle cell lymphoma.
Prev page
1
2
3
Next page